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1418Background: Risk-adjusted outcomes of surgical care are important for quality and cost assessments. Although
cardiac surgery is commonly studied, risk-adjusted analysis of excess costs of lung resection has not been pur-
sued.
Methods:We used 2002 to 2005 National Inpatient Sample of the Healthcare Cost and Utilization Project data
to evaluate adverse outcomes and costs in elective lung resections in hospitals with more than 20 cases during
that period. Adverse outcomes were inpatient death or excessive risk-adjusted postoperative stay. Logistic
models were defined to predict adverse outcomes. Linear models were designed to predict costs. Hospital-
specific adverse outcome rates and costs were measured to define performance outliers. Cost-effective reference
hospitals were used to define total excess costs.
Results: Among 12,182 patients at 215 hospitals undergoing lung resection, there were 336 inpatient deaths
(2.8%) and 880 live discharges with prolonged risk-adjusted postoperative stay (7.2%). Predictive models
for mortality and risk-adjusted postoperative stay had C statistics of 0.773 and 0.643, respectively. There
were 11 ineffective hospitals (5.1%) with excessive adverse outcomes (P<.005) and 34 inefficient hospitals
(15.8%) meeting quality measures but with higher than predicted costs (P<.0005). Ineffective hospitals had
costs $1020 per case lower than predicted. Inefficient hospitals had costs $9978 higher than predicted.
Conclusions: Inefficiency is the major factor in excess inpatient costs associated with lung resection in this
model. Although refinements in databases, including total physician costs and postdischarge adverse event costs,
will alter models, excess costs of lung resection appear to be driven by inefficiency, not adverse outcomes.
(J Thorac Cardiovasc Surg 2011;142:1418-22)Improvement in the quality of surgical care has been
a continuing goal for all surgeons and has recently be-
come the focus of attention by governmental and regula-
tory agencies. Not only is reduced patient morbidity
desirable as a goal in itself, but complications of major
operations have been identified as important sources of
excess costs.1 Reduction of surgical complications can
be an important component in efforts to contain health
care costs.
The Surgical Care Improvement Project has been a high
visibility government initiative focused on the reduction of
complications and associated costs related to surgical site
infections, postoperatively myocardial events, deep venous
thrombophlebitis and pulmonary embolism, and post-
operative pulmonary failure.2 In its initial design of quality
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The Journal of Thoracic and Cardiovascular SurImprovement Project targeted high-volume, high-cost pro-
cedures of coronary artery bypass grafting, total hip and
knee replacement, hysterectomy, peripheral vascular sur-
gery, and colon resection.3 Lung resection has not been a fo-
cus of the Surgical Care Improvement Project to this point
in time.
Our group has analyzed results of major surgical proce-
dures to characterize the relationship between currently
achievable improvements in quality and those in reductions
in the cost of surgical care. The objective of these analyses
has been to identify reference hospitals that meet analyti-
cally derived quality performance and efficiency standards.
These reference hospitals can be used to calibrate episode-
based, risk-adjusted payment models designed to reward
hospitals and surgeons financially for delivering cost-
effective surgical care.
Both the Society of Thoracic Surgery4 and the European
Society of Thoracic Surgery5 have demonstrated consider-
able interest in improving the quality of surgical care for pa-
tients undergoing lung resections. Currently, mortality and
morbidity vary substantially among hospitals; however,
there is little information available about associated varia-
tions in costs. This study applies methods that distinguish
between the costs of complications (ie, ineffective care)
and routine costs (ie, clinical efficiency). We hypothesize
that potential savings and improved quality in lung resec-
tions can be identified through comparisons with cost-
effective reference hospitals.gery c December 2011
Abbreviation and Acronym
ICD-
9-CM
¼ International Classification of Diseases,
Ninth Revision, Clinical Modification
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SMATERIALS AND METHODS
We studied elective lung resection in patients with International Classi-
fication of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)
codes of 32.3 through 32.5 and 32.9. These were selected from the years
2002 to 2005 with the National Inpatient Sample of the Healthcare Cost
and Utilization project supplied by the Agency for Healthcare Research
and Quality.6 Only elective operations performed within 2 days of admis-
sion at hospitals with 20 or more cases during the study period were in-
cluded in the analysis. Patients at hospitals that failed to pass previously
described data quality screens7 were excluded from the study.
Inpatient mortality and prolonged postoperative risk-adjusted stays for
live discharges were classified as adverse outcomes. The hospital cost for
each surgical case was computed from total billed charges and the hospi-
tal’s cost-to-charge ratio.8 Costs were adjusted to 2005 dollars. Predicted
values were adjusted by hospital-specific wage indices and by regional
cost characteristics of urban versus rural hospitals.
A list of ICD-9-CM diagnosis codes for generic and procedure-specific
complications was created. Risk factors for possible inclusion in predictive
models for patient outcomes were crafted from demographic, diagnostic,
and procedural hospital discharge data (Table 1). The generic set of diag-
nostic risk factors developed by Elixhauser and colleagus9 was modified
and expanded. Dummy variables for lobectomy and for pneumonectomy
were created to account for potentially greater morbidity and cost associ-
ated with these procedures. Hospital dummy variables were used during
variable selection and model calibration to minimize hospital-specific in-
fluences on the final predictive equations.10
All analyses were performed with SAS statistical software (version
9.1.3; SAS Institute, Inc, Cary, NC).
Prolonged Risk-Adjusted Postoperative Stay and
Adverse Outcomes
Forward stepwise linear regression was used to derive a predictive
model for routine postoperative stay for live discharges without ICD-9-
CM–coded complications. Risk-adjusted postoperative stay was computed
as the difference between the observed and the predicted postoperative stay
for each live discharge.
Hospital-specific XmR control charts were used to identify live dis-
charges with risk-adjusted postoperative stay longer than a 3-SD upper
control limit (ie, outliers).11,12 Outliers were eliminated from each
hospital’s reference database, and a new 3-SD upper control limit was de-
rived. This process was repeated until no case remaining in a reference da-
tabase had a risk-adjusted postoperative stay that exceeded the 3-SD upper
threshold. Outliers were classified as having had prolonged risk-adjusted
postoperative stay; other live discharges were classified as routine cases.
Forward stepwise logistic regression was used to derive predictive equa-
tions for inpatient mortality for all discharges and for prolonged risk-
adjusted postoperative stay for live discharges. The intercepts of these
equations were recalibrated so that total observed and predicted values
were equal after hospital dummy variables had been removed. The pre-
dicted probability of an adverse outcome (ie, death or a prolonged risk-
adjusted postoperative stay) for each case was computed as p{death}þ
[(1 p{death}) $ p{prolonged risk-adjusted postoperative stay }], where
p{death} is the probability of death and p{prolonged risk-adjusted postop-
erative stay} is the probability of a prolonged risk-adjusted postoperative
stay. C statistics were used to determine the discriminatory power of the fi-
nal predictive equations.The Journal of Thoracic and CarHospital Costs
Forward stepwise linear regression was used to derive a predictive
model for routine hospital costs on the basis of data for all routine cases.
A lower limit for routine hospital costs was derived by computing each hos-
pital’s 10th percentile cost and then setting this lower limit equal to the 10th
percentile of these costs at all hospitals. This is a method that has previ-
ously been used to prevent cases with extremely low cost from adversely
influencing the intercept of the cost model.13-15 Estimated routine costs
for cases with adverse outcomes were computed by the following
formula: Estimated costs (adverse outcomes) ¼ Predicted routine cost
(model) $ (observed routine costs of reference hospital)/(predicted costs
of reference hospital). Use of this formula permitted adjustment of the
raw calculation from the coefficients of the national model to the pattern
of expected routine costs for the reference hospital from which the
adverse outcome care originated.
Excess hospital costs attributable to adverse outcomes were computed
by subtracting estimated routine costs from actual hospital costs for cases
with adverse outcomes. When computed excess hospital costs were nega-
tive, they were set to zero. When the computed excess hospital cost for
a case was 10 times greater than the corresponding predicted routine
cost, the excess cost was set to 10 times the predicted routine cost. Costs
that exceeded this upper threshold were assigned to a stop-loss pool.
This 10-fold threshold was arbitrarily chosen because it was indexed to pre-
dicted costs and consistently has involved only a small number of cases that
consisted of a small total cost (1%) of the whole population but represents
a truly catastrophic cost for the incident hospital.13-15
Forward stepwise linear regression was used to derive a predictive
model for excess hospital costs of adverse outcomes on the basis of data
for all cases with adverse outcomes. A dummy variable for inpatient mor-
tality was added to the set of candidate risk factors. For each case, the pre-
dicted cost of a possible adverse outcome was computed as the sum of the
probability of dying times the predicted excess cost associated with inpa-
tient mortality and the probability of being discharged alive with a pro-
longed risk-adjusted postoperative stay multiplied by the predicted
excess cost associated with a prolonged risk-adjusted postoperative stay.
Each hospital’s predicted costs were adjusted to reflect regional wage indi-
ces and the hospital’s urban or rural location. To determine the explanatory
power of the final predictive equations, r2 statistics were used.
Cost-Effective Reference Hospitals
To identify ineffective hospitals with significantly higher-than-average
adverse outcome rates, predicted adverse outcome rates were standardized
so that the total predicted adverse outcomes equaled the total observed ad-
verse outcomes for the study population. Outlier hospitals whose observed
adverse outcome rates exceeded their predicted adverse outcome rates by
more than 2.56 SD (P<.005) were classified as ineffective and removed
from the reference data set. This arbitrary level was chosen because at
most 1 or 2 hospitals would be expected by chance alone to exceed this
threshold. Predicted adverse outcome rates for the remaining hospitals
were recalculated so that the total predicted and observed rates were equal,
and any newly identified outlier hospitals were removed from the reference
data set. This process was repeated until no further outlier hospitals could
be identified.
To identify inefficient hospitals with substantially higher than average
costs, predicted costs for routine cases at effective hospitals (ie, hospitals
remaining in the reference data set after ineffective hospitals were re-
moved) were standardized so that total predicted costs equaled total ob-
served costs. Outlier hospitals whose observed per case routine costs
were more than twice their predicted per case routine costs and whose ob-
served routine costs exceeded their predicted routine costs by more than
3.29 SD (P<.0005) were classified as inefficient and removed from the ref-
erence data set. Because costs are continuous variables and relatively small
differences can assume statistical significance, a more extreme threshold
was chosen for inefficient outliers than for ineffective ones. Predicted perdiovascular Surgery c Volume 142, Number 6 1419
TABLE 1. Details of the candidate clinical risk factors used in designing the risk model for patients undergoing lung resection
Hypertension Ischemic heart disease Cardiomyopathy Valvular heart disease
Chronic congestive heart failure Chronic pulmonary heart failure Aortic aneurysm Peripheral vascular disease
Chronic pulmonary disease Esophageal reflux Chronic peptic ulcer Chronic hepatitis
Chronic liver disease
(nonhepatitis)
Inflammatory bowel disease Malabsorption Chronic renal failure
Other renal disease Urinary tract obstruction HIV/AIDS Diabetes
Other diabetic complications Hyperlipidemia Hypothyroidism Parathyroid disease
Gout Neurohypoadrenal dysfunction Long-term steroid use Obesity
Malnutrition/weight loss Rheumatoid arthritis/collagen
vascular disease
Cutaneous ulcer/complicated
varicose veins
Blood loss anemia
Deficiency anemia Other anemia/hypersplenism Clotting abnormality Polycythemia/hypercoagulable
state
Chronic cerebrovascular disease Paralysis Other neurologic disease Alcohol abuse
Drug abuse (nonalcohol) Alzheimer disease/dementia Neurotic depression Psychosis
Primary malignancy Metastatic cancer Lymphatic/hematopoietic
malignancy
Age in 10-y increments
Sex Lobectomy Pneumonectomy
Not all risk factors achieved significance, and accordingly not all were represented in the final model.
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predicted and observed costs were equal, and any newly identified outlier
hospitals were removed from the reference data set. This process was re-
peated until no further outlier hospitals could be identified.
Hospitals remaining in the final reference data set were classified as
cost-effective. Intercepts for logistic predictive models and intercepts and
coefficients for linear predictive models were recalculated so that the total
observed and total predicted values were equal for cases at cost-effective
hospitals. The quality and the cost of care at each hospital were assessed
by comparing observed outcomes with predicted outcomes that had been
standardized with only cost-effective reference hospitals.
RESULTS
The study population consisted of 12,182 patients from
215 hospitals that passed the screens for data quality. There
were 336 (2.8%) inpatient deaths and 880 (7.2%) live dis-
charges with prolonged risk-adjusted postoperative stay.
The final predictive model for mortality had a C statistic
of 0.773; the final predictive model for prolonged risk-
adjusted postoperative stay had a C statistic of 0.643. The
average cost for 10,966 routine cases was $16,586, and
the average excess cost associated with 1216 adverse out-
comes was $31,729. The final predictive model for routine
cost had an r2 statistic of 0.053; the final predictive model
for excess cost had an r2 statistic of 0.073.
There were 11 ineffective hospitals (5.1%) with signifi-
cantly higher than average adverse outcome rates. Ineffec-
tive hospitals had 1047 patients (11.5%), with 26 deaths
(2.5%) and 159 live discharges with prolonged risk-
adjusted postoperative stay (15.2%). The adverse outcome
rate of 17.7% for the ineffective hospitals was significantly
higher than the corresponding predicted adverse outcome
rate of 8.7% (P<.005). No hospital was found to be a sta-
tistical outlier if only death rates were evaluated according
only to the mortality prediction model. At the ineffective
hospitals, the average hospital cost was $14,920 per routine
case, and the average additional cost of an adverse outcome1420 The Journal of Thoracic and Cardiovascular Surwas $23,097. The average per case total cost of $16,365 at
ineffective hospitals was significantly lower than the corre-
sponding predicted total cost of $17,385 (P<.001).
There were 34 inefficient hospitals (15.8%) that had sig-
nificantly higher than predicted routine costs. Inefficient
hospitals had 1506 patients (12.4%), with 59 deaths
(3.9%) and 76 live discharges with prolonged risk-
adjusted postoperative stay (5.0%). The adverse outcome
rate of 9.0% for inefficient hospitals was not significantly
different from the corresponding predicted adverse out-
come rate of 9.7%. At the inefficient hospitals, the average
hospital cost was $24,347 per routine case, and the average
additional cost of an adverse outcome was $46,391. The av-
erage per case total cost of $26,323 at the inefficient hospi-
tals was significantly higher than the corresponding
predicted total cost of $16,345 (P<.001).
There were 170 cost-effective hospitals (79.0%) in the
reference data set. Reference hospitals had 9629 patients
(79.0%), with 251 deaths (2.6%) and 645 live discharges
with prolonged risk-adjusted postoperative stay (6.7%).
At reference hospitals, the average hospital cost was
$15,589 per routine case, the average additional cost of an
adverse outcome was $31,302, and the average per case to-
tal hospital cost was $17,051.
Cost comparisons between ineffective, inefficient, and
reference hospitals are represented in Figure 1. Figure 2 is
a scatterplot of adverse outcome rates and average costs
per case of ineffective and inefficient hospitals. These rep-
resent the actual, and not risk adjusted, adverse outcome
rates and costs.
The total cost of $220,963,270 for all cases at all hospitals
was $13,958,564 (6.3%) higher than the corresponding pre-
dicted cost of $207,004,706 that was derived from the perfor-
mance of the cost-effective reference hospitals. Ineffective
hospitals had total costs that were $1,067,897 (6.2%) lowergery c December 2011
FIGURE 1. This is a graphic representation of the costs per case for inef-
fective, inefficient, and reference hospitals. Within each hospital group, the
costs of routine cases, adverse outcome cases, and all cases together are
represented.
FIGURE 2. This is a scatterplot chart of adverse outcome rates plotted
against average costs per case of ineffective and inefficient hospitals.
The average of all reference hospitals is represented by the large triangle.
These are actually observed rates and not observed minus predicted rates.
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were $15,026,461 (37.9%) higher than predicted.DISCUSSION
In this study, the effectiveness and efficiency of hospital
care for patients undergoing elective lung resections were
assessed by comparing inpatient adverse outcome rates
and routine costs with the corresponding predicted values
derived from the performance of a reference group of
cost-effective hospitals. It is noteworthy that even when ex-
cess hospital costs associated with adverse outcomes were
added to the routine costs of ineffective hospitals, the total
costs at these ineffective hospitals were lower than the pre-
dicted costs derived from the performance of cost-effective
hospitals. This finding is consistent with previously pub-
lished analyses of elective colon resection, total joint re-
placement, coronary artery bypass grafting, hysterectomy,
and peripheral vascular reconstruction.13-15 Thus although
quality improvement initiatives will reduce excess
hospital costs associated with the prevention of specific
adverse outcomes, these data indicate that additional costs
may be required to achieve better clinical results inThe Journal of Thoracic and Carsuboptimally performing hospitals. The greatest
opportunity for the reduction of excess inpatient costs
appears to depend primarily on reducing routine costs at
inefficient hospitals.
The analytic methods used in this study are ideally suited
to support episode-based, risk-adjusted bundled payments
for surgical care, with quality and cost indexed to the perfor-
mance of cost-effective reference hospitals. Through the
use of more comprehensive data, such as may be obtained
from all-payer claims databases, these methods can be ex-
panded to incorporate the cost of professional inpatient ser-
vices and postdischarge outcomes and costs. Only with such
expansion can the full spectrum of costs for an inpatient ep-
isode be fully defined.
Bundled payments for entire episodes of care have been
recommended by the Medicare Payment Advisory Com-
mission.16 The Centers for Medicare andMedicaid Services
have launched demonstration projects in elective joint re-
placement and cardiac surgery to test this method of pay-
ment.17 Episode-based payment that transfers financial
responsibility for the excess cost of complications from
payers to providers is a central component of the Geisinger
Clinic’s ProvenCare program.18 As demonstrated in this
study, fair prospective prices for this type of health carewar-
ranty can be established by multiplying predicted adverse
outcome rates by predicted excess costs adversediovascular Surgery c Volume 142, Number 6 1421
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warranties would enable effective, efficient hospitals and
physicians to increase their net revenue and would provide
strong financial incentives to coordinate care and improve
clinical performance with or without actual vertical integra-
tion of hospitals and physicians.20
This study is a first effort to model the quality and cost of
lung resection, and it has limitations. Hospital claims data
such as those used in this study often fail to provide the clin-
ical detail required to assess fully the risk-adjusted health
care outcomes and costs. Evolving technologies such as
video-assisted thoracoscopic21 and robotic techniques22
are not captured; however, they should be more easily cap-
tured in future cost and quality assessments. Clinical regis-
tries such as the Society of Thoracic Surgeons cardiac and
lung cancer databases are better suited to determine preop-
erative risk more fully, assess unique and evolving techno-
logical interventions, and completely identify surgical
complications. These databases, however, can be costly to
develop and to maintain. Clinically enhanced claims data-
bases that include present-on-admission codes to differenti-
ate hospital-acquired complications from preoperative risk
factors and numeric laboratory data from electronic data re-
positories have the potential to be cost-effective alternatives
to costly clinical registries for monitoring risk-adjusted hos-
pital outcomes and costs.23,24
Another limitation lies in assessment of the severity of
coded complications. Generic surgical complications in-
clude more than 40 groups of ICD-9-CM diagnosis codes,
and additional codes are required to identify unique compli-
cations of specific procedures (eg, bronchopleural fistula af-
ter lung resection). Many of these diagnoses include
complications that can range from trivial physiologic de-
rangements to life-threatening clinical conditions. Some
may not be apparent unless specific diagnostic tests are per-
formed. Documentation and coding of hospital-acquired
complications thus may vary widely among hospitals, par-
ticularly for less serious adverse events. In this study, prob-
lems arising from inconsistencies in the diagnosis and
reporting of hospital-acquired complications were mini-
mized by limiting measured complications to those that
were associated with inpatient mortality or with signifi-
cantly longer than predicted postoperative stay.
In summary, this study demonstrates how analyses of
risk-adjusted clinical outcomes and costs can be combined
to identify reference cost-effective providers, create quality
and efficiency standards derived from the performance of
these cost-effective providers, and evaluate the relationship
between quality and cost. It provides strong evidence that
substantial reductions in hospitals costs cannot be achieved
without improving the efficiency of hospital care. It pres-
ents a blueprint with more complete data sets for how bun-
dled payments can be designed and calibrated to reward
providers that deliver coordinated cost-effective care.1422 The Journal of Thoracic and Cardiovascular SurWith the development of integrated clinically enhanced
claims databases, this analytic infrastructure can serve as
the basis for a reformed health care delivery system that rec-
ognizes and rewards high-quality clinical care, preserves
professional autonomy, and encourages the efficient use
of clinical resources.
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